Filippi M, Preziosa P, Meani A, Dalla Costa G, Mesaros S, Drulovic J, et al.; MAGNIMS Study Group. Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study. Neurology. 2022 Jan 4;98(1):e1-e14. [Pubmed]
Lebrun-Frenay C, Kantarci O, Siva A, Sormani MP, Pelletier D, Okuda DT; 10-year RISC study group on behalf of SFSEP, OFSEP. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020 Aug;88(2):407-17. [Pubmed]
Lebrun-Frénay C, Rollot F, Mondot L, Zephir H, Louapre C, Le Page E, et al.; RISC, SFSEP, and OFSEP Investigators. Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome. JAMA Netw Open. 2021 Oct 1;4(10):e2128271. [Pubmed]
Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, et al.; MSBase Study Group. Defining secondary progressive multiple sclerosis. Brain. 2016 Sep;139(Pt 9):2395-405. [Pubmed]
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014 Jul 15;83(3):278-86. [Pubmed]
Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 Apr;46(4):907-11. [Pubmed]
Meca-Lallana V, Berenguer-Ruiz L, Carreres-Polo J, Eichau-Madueño S, Ferrer-Lozano J, Forero L, et al. Deciphering Multiple Sclerosis Progression. Front Neurol. 2021 Apr 7;12:608491. [Pubmed]
Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol. 2012 Feb;11(2):157-69. [Pubmed]
Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, et al. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 2015 Aug 25;85(8):722-9. Erratum in: Neurology. 2015 Oct 13;85(15):1355. [Pubmed]
Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009 Mar 3;72(9):800-5. Erratum in: Neurology. 2009 Apr 7;72(14):1284. [Pubmed]
Scalfari A, Neuhaus A, Daumer M, Muraro PA, Ebers GC. Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):67-75. [Pubmed]
Siva A. Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis. Neurol Clin. 2018 Feb;36(1):69-117. [Pubmed]
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. [Pubmed]
Tintore M, Cobo-Calvo A, Carbonell P, Arrambide G, Otero-Romero S, Río J, et al. Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome. Neurology. 2021 Oct 26;97(17):e1641-e1652. [Pubmed]
Vidal-Jordana A, Montalban X. Multiple Sclerosis: Epidemiologic, Clinical, and Therapeutic Aspects. Neuroimaging Clin N Am. 2017 May;27(2):195-204. [Pubmed]
Vollmer TL, Nair KV, Williams IM, Alvarez E. Multiple Sclerosis Phenotypes as a Continuum: The Role of Neurologic Reserve. Neurol Clin Pract. 2021 Aug;11(4):342-51. [Pubmed]
Yamout B, Al Khawajah M. Radiologically isolated syndrome and multiple sclerosis. Mult Scler Relat Disord. 2017 Oct;17:234-7 [Pubmed]